In a study examining new therapies for pregnant women, which party must provide consent?

In research involving pregnant women, obtaining informed consent is a critical ethical requirement. The correct approach is that the pregnant woman herself must provide consent for her participation in the study. This is grounded in the principle of autonomy, which recognizes that individuals have the right to make informed decisions regarding their own health and medical treatments.

While there may be discussions about the involvement or views of the unborn child's father or family, it is the pregnant woman who has the legal and ethical capacity to consent to her own participation in research. This is designed to empower her choices while also protecting her rights and welfare, ensuring that she is fully informed about the risks and benefits associated with the research being conducted.

Including her family or requiring consent from both parents could lead to complications regarding who has the authority to consent, as well as potential undue pressure on the pregnant participant. It is also important to note that healthcare providers cannot provide consent on behalf of patients; their role is to inform and support the patient in making her own decision.